TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12120884

Group type: EXPERIMENTAL
Intervention: IFN‐alpha2a 9 million units 3x week for 6 months with HBV vaccine 20 microg given on 0, 1 and 2 months
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: IFN‐alpha2a 6 million units 3x week plus famciclovir 250 mg 3x day for 6 months
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: IFN‐alpha2a 6 million units 3x week plus lamivudine 100 mg/day for 6 months
Number of subjects: 29
Study: 10710240

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen delivery (90 min daily at 2.2 Absolute Atmosphere for three cycles)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no hyperbaric oxygen delivery)
Number of subjects: 48
Study: 8607307

Group type: EXPERIMENTAL
Intervention: Alkalinized 0.5% lignocaine (pH 7.2-7.3)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal 0.5% lignocaine (pH 5.2-5.3)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Alkalinized 0.5% lignocaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal 0.5% lignocaine
Number of subjects: 40
Study: 2669648

Group type: EXPERIMENTAL
Intervention: PGI2‐A (300 micrograms/L)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Potassium cardioplegia (control)
Number of subjects: 45
Study: 1033056

Group type: EXPERIMENTAL
Intervention: 8 mg glisoxepide in the morning and 4 mg in the evening
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Tablets taken half-an-hour before breakfast
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Tablets taken one hour before breakfast
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard diet
Number of subjects: 11
Study: 30638840

Group type: EXPERIMENTAL
Intervention: Intermittent calf compression low frequency (ICLF; 4 s on, 11 s off)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Intermittent calf compression high frequency (ICHF; 4 s on, 6 s off)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Static elastic compression stockings
Number of subjects: 34

Group type: COMPARATOR
Intervention: Static inelastic compression stockings
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Intermittent calf compression at 0–60 mm Hg (ICLF)
Number of subjects: 34
Study: 28427286

Group type: EXPERIMENTAL
Intervention: NAVIGATE, a coordinated specialty care program
Number of subjects: 399

Group type: COMPARATOR
Intervention: Usual community care
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Obtaining SSA disability benefits
Number of subjects: 399
Study: 24107979

Group type: EXPERIMENTAL
Intervention: Joint protection
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Hand exercises
Number of subjects: 257
Study: 22189755

Group type: EXPERIMENTAL
Intervention: Intensive structured monitoring (ISM) group
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Active control (AC) group
Number of subjects: 1000
Study: 22136024

Group type: EXPERIMENTAL
Intervention: Retained needling at Neiguan (PC 6) and Jianshi (PC 5) for 20 min
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-retained needling at Neiguan (PC 6) and Jianshi (PC 5) for 20 min
Number of subjects: 60
Study: 19321672

Group type: EXPERIMENTAL
Intervention: Urokinase
Number of subjects: 19

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 19
Study: 16330055

Group type: EXPERIMENTAL
Intervention: Prism adaptation (PA) treatment for 10 daily sessions
Number of subjects: 16

Group type: COMPARATOR
Intervention: General cognitive stimulation (control group)
Number of subjects: 16
Study: 12974427

Group type: EXPERIMENTAL
Intervention: Streptokinase (2.5 lac units in 100 ml of normal saline instilled intrapleurally for 6 consecutive days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (100 ml of normal saline instilled intrapleurally for 6 days)
Number of subjects: 24
Study: 10917989

Group type: EXPERIMENTAL
Intervention: ICA occlusion (symptomatic or asymptomatic)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: ICA occlusion with atherosclerotic stenosis less than 75% of the contralateral ICA
Number of subjects: 41
Study: 8868788

Group type: EXPERIMENTAL
Intervention: Femoral caliper intervention for controlling leg length during hip replacement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard hip replacement procedure without the femoral caliper
Number of subjects: 0
Study: 1638588

Group type: EXPERIMENTAL
Intervention: Cefaclor AF (375 mg twice daily)
Number of subjects: 563

Group type: COMPARATOR
Intervention: Cefaclor (250 mg three times daily)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Cefaclor AF and Cefaclor
Number of subjects: 563
Study: 6700601

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy without lithium carbonate
Number of subjects: 0
Study: 30878226

Group type: EXPERIMENTAL
Intervention: Laser peripheral iridotomy in treated eyes
Number of subjects: 889

Group type: COMPARATOR
Intervention: Untreated eyes (control)
Number of subjects: 889
Study: 30548118

Group type: EXPERIMENTAL
Intervention: M. officinalis capsules (700 mg/d)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 29798118

Group type: EXPERIMENTAL
Intervention: Drug treatment and psychological intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pure drug therapy (Control)
Number of subjects: 60
Study: 25087210

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training, device training and home treatment (experimental group)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional rehabilitation treatment (control group)
Number of subjects: 19
Study: 23731432

Group type: EXPERIMENTAL
Intervention: Negative emotional material
Number of subjects: 2

Group type: COMPARATOR
Intervention: Neutral material
Number of subjects: 2
Study: 20734043

Group type: EXPERIMENTAL
Intervention: A‐SB group (anatomical single-bundle ACL reconstruction)
Number of subjects: 20

Group type: COMPARATOR
Intervention: A‐DB group (anatomical double-bundle ACL reconstruction)
Number of subjects: 20
Study: 18343353

Group type: EXPERIMENTAL
Intervention: Oxytocin (24 IU)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 16809572

Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proinflammatory cytokines (interleukin‐1beta and interferon‐gamma)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Geranylgeranyl transferase inhibitor, toxin B, C3 exoenzyme, Y‐27632
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no atorvastatin treatment)
Number of subjects: 0
Study: 12623473

Group type: EXPERIMENTAL
Intervention: Active management of labour
Number of subjects: 448

Group type: COMPARATOR
Intervention: Routine labour management
Number of subjects: 448
Study: 11374209

Group type: EXPERIMENTAL
Intervention: Continuous oxygen therapy
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Oxygen
Number of subjects: 4

Group type: COMPARATOR
Intervention: Nocturnal oxygen
Number of subjects: 4

Group type: COMPARATOR
Intervention: Long term oxygen
Number of subjects: 4
Study: 9242853

Group type: EXPERIMENTAL
Intervention: Cups with larger handles
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cups with smaller handles
Number of subjects: 30
Study: 8011570

Group type: COMPARATOR
Intervention: Atenolol 50 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg and slow release nifedipine 20 mg twice a day
Number of subjects: 27
Study: 2887542

Group type: EXPERIMENTAL
Intervention: Beta-adrenergic blockade (celiprolol, 600 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Calcium channel blockade (diltiazem, 30 or 60 mg four times daily)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 30982141

Group type: EXPERIMENTAL
Intervention: Hand Massage (HM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Therapeutic Touch (TT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 30
Study: 29599391

Group type: EXPERIMENTAL
Intervention: Collagenase clostridium histolyticum injection followed by limited fasciectomy in non-responsive cases
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percutaneous needle fasciotomy followed by limited fasciectomy in non-responsive cases
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primary limited fasciectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 26914400

Group type: EXPERIMENTAL
Intervention: Early amniotomy
Number of subjects: 245

Group type: COMPARATOR
Intervention: Repeat PGE2 vaginal gel
Number of subjects: 245
Study: 25488560

Group type: EXPERIMENTAL
Intervention: Living ACTS educational intervention
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control video
Number of subjects: 268
Study: 23123869

Group type: EXPERIMENTAL
Intervention: Lower levels of adult activity in interaction at one year
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Lower levels of adult speech in interaction at one year
Number of subjects: 180
Study: 22000583

Group type: EXPERIMENTAL
Intervention: Low dose alcohol (1-2 mL)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: High dose alcohol (>2 mL)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 76
Study: 18471252

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic/docosahexaenoic PUFA supplements
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 16509867

Group type: EXPERIMENTAL
Intervention: Endoscopic variceal ligation (EVL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 100
Study: 12668363

Group type: EXPERIMENTAL
Intervention: Fluoxetine, 20 mg/day
Number of subjects: 840

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 840
Study: 10975513

Group type: COMPARATOR
Intervention: Prednisone (60 mg/m2 per day for 7 days)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ATG/prednisone (15 mg/kg ATG bid plus 20 mg/m2 prednisone bid for 5 days, followed by an 8-week prednisone taper)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ATG/prednisone
Number of subjects: 100
Study: 9172131

Group type: EXPERIMENTAL
Intervention: Patients with sporadic ALS
Number of subjects: 11

Group type: COMPARATOR
Intervention: Age-matched control subjects
Number of subjects: 11
Study: 8470851

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate, 400 micrograms two times daily during years 3 and 4
Number of subjects: 56

Group type: COMPARATOR
Intervention: Bronchodilator therapy (salbutamol, 400 micrograms, or ipratropium bromide, 40 micrograms) during the first 2 years
Number of subjects: 56
Study: 3549971

Group type: EXPERIMENTAL
Intervention: Rimantadine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 63
Study: 29777534

Group type: EXPERIMENTAL
Intervention: Dental treatment provided by a dentist four to five times a week, in addition to routine oral hygiene.
Number of subjects: 254

Group type: COMPARATOR
Intervention: Routine oral hygiene including topical application of chlorhexidine provided by ICU nursing staff.
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Dental treatment
Number of subjects: 254
Study: 26864095

Group type: EXPERIMENTAL
Intervention: Doublebase Dayleve gel (DELP)
Number of subjects: 36
Study: 25025057

Group type: EXPERIMENTAL
Intervention: Beta-glucan rich oat bread
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wheat fiber bread (Control)
Number of subjects: 60
Study: 22562609

Group type: EXPERIMENTAL
Intervention: Daunorubicin
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: CBR1 inhibition
Number of subjects: 104
Study: 16040885

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 12444180

Group type: EXPERIMENTAL
Intervention: Transhiatal esophagectomy
Number of subjects: 220

Group type: COMPARATOR
Intervention: Transthoracic esophagectomy with extended en bloc lymphadenectomy
Number of subjects: 220
Study: 9696300

Group type: EXPERIMENTAL
Intervention: Gabapentin (GBP) 600 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) 400 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study: 7650108

Group type: EXPERIMENTAL
Intervention: Caffeine (300 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (decaffeinated coffee)
Number of subjects: 24
Study: 2756353

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 200 mg b.i.d. iv. for two days, followed by oral administration with 750 mg b.i.d. for a total of 14 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Doxycycline plus metronidazole according to a similar scheme of administration
Number of subjects: 36
Study: 324570

Group type: EXPERIMENTAL
Intervention: Cytotoxic treatment
Number of subjects: 92

Group type: COMPARATOR
Intervention: Endocrine treatment
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Cytotoxic treatment (premenopausal women)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Endocrine treatment (ovarian ablation, premenopausal women)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Endocrine treatment (tamoxifen, postmenopausal women)
Number of subjects: 92
Study: 30760393

Group type: EXPERIMENTAL
Intervention: Modified Constraint-Induced Movement Therapy (mCIMT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Bimanual Therapy (BIM)
Number of subjects: 33
Study: 28003034

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Exercise (PRE)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Compensatory Workplace Exercise (CWE)
Number of subjects: 352
Study: 25910378

Group type: COMPARATOR
Intervention: LAC (lansoprazole 1 mg/kg/day, amoxicillin 50 mg/kg/day, clarithromycin 14 mg/kg/day for 14 days)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: LACE (LAC + vitamin E 200 IU/day for 14 days)
Number of subjects: 90
Study: 22868073

Group type: EXPERIMENTAL
Intervention: Computer-assisted total knee arthroplasty
Number of subjects: 111

Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Coronal alignment within 3° of neutral
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Coronal alignment greater than 3°
Number of subjects: 111
Study: 21122499

Group type: EXPERIMENTAL
Intervention: Budesonide-MMX(R) 9 mg tablets
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 18765162

Group type: EXPERIMENTAL
Intervention: Biolimus-eluting stent (n=857)
Number of subjects: 1707

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (n=850)
Number of subjects: 1707

Group type: EXPERIMENTAL
Intervention: Biolimus-eluting stent
Number of subjects: 1707

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent
Number of subjects: 1707
Study: 16168062

Group type: EXPERIMENTAL
Intervention: formoterol 12 microg twice daily
Number of subjects: 13

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 13
Study: 10087413

Group type: EXPERIMENTAL
Intervention: 25 mg oral methotrexate followed by 800 micrograms vaginal misoprostol 7 days later
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: 50 mg oral methotrexate followed by 800 micrograms vaginal misoprostol 7 days later
Number of subjects: 310

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 310
Study: 7587919

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (administered 3 or 4 times a day)
Number of subjects: 22
Study: 2215996

Group type: EXPERIMENTAL
Intervention: Hygrobac DAR 352 filter
Number of subjects: 0
Study: 419422

Group type: EXPERIMENTAL
Intervention: Atropine intramuscularly
Number of subjects: 51

Group type: COMPARATOR
Intervention: No atropine (Control)
Number of subjects: 51
Study: 31359814

Group type: EXPERIMENTAL
Intervention: Random forest algorithm
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Ridge regression algorithm
Number of subjects: 232
Study: 31138020

Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 161

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 161
Study: 27771133

Group type: EXPERIMENTAL
Intervention: Unified Protocol for the Treatment of Emotional Disorders in Adolescents (UP‐A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 0
Study: 26319651

Group type: EXPERIMENTAL
Intervention: Induction of labour (IoL)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Expectant management (EM)
Number of subjects: 234
Study: 23292538

Group type: EXPERIMENTAL
Intervention: 0.025% betamethasone valerate cream
Number of subjects: 47

Group type: COMPARATOR
Intervention: 0.05% betamethasone valerate cream
Number of subjects: 47
Study: 19256406

Group type: EXPERIMENTAL
Intervention: Reinforcement course at 6 months (RCG)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Monthly phone contact (PHCG)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 70
Study: 16500236

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (Zometa) with Letrozole
Number of subjects: 0
Study: 15022811

Group type: EXPERIMENTAL
Intervention: Outpatient physiotherapy following total knee arthroplasty
Number of subjects: 120

Group type: COMPARATOR
Intervention: No outpatient physiotherapy following total knee arthroplasty
Number of subjects: 120
Study: 11220085

Group type: EXPERIMENTAL
Intervention: Pacemaker patients with increased pacing rate
Number of subjects: 32

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 32
Study: 9571270

Group type: EXPERIMENTAL
Intervention: New spherical soft contact lenses
Number of subjects: 35

Group type: COMPARATOR
Intervention: Spectacle correction
Number of subjects: 35
Study: 8156285

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine tablet (155 mg)
Number of subjects: 9
Study: 29194749

Group type: EXPERIMENTAL
Intervention: Teriparatide (TPTD) 20 μg/d by subcutaneous injection
Number of subjects: 58

Group type: COMPARATOR
Intervention: Zoledronic Acid (ZOL) 5 mg/yr by intravenous infusion
Number of subjects: 58
Study: 26928392

Group type: EXPERIMENTAL
Intervention: 5 mg melatonin nightly for 5 nights
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 25630243

Group type: EXPERIMENTAL
Intervention: Glucosamine-sulfate (1000 mg daily, for 8 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 23337343

Group type: EXPERIMENTAL
Intervention: High monounsaturated fat diet (diet M)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: High polyunsaturated fat diet (diet P)
Number of subjects: 258
Study: 20848590

Group type: EXPERIMENTAL
Intervention: Automation-assisted screening
Number of subjects: 503391

Group type: COMPARATOR
Intervention: Conventional cytological screening
Number of subjects: 503391
Study: 18828958

Group type: EXPERIMENTAL
Intervention: Duloxetine (40-120 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16773618

Group type: EXPERIMENTAL
Intervention: Low-protein products (LPP) diet
Number of subjects: 18

Group type: COMPARATOR
Intervention: Balanced diet
Number of subjects: 18
Study: 14618512

Group type: EXPERIMENTAL
Intervention: Fixed combinations of LABA and ICS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 11054911

Group type: EXPERIMENTAL
Intervention: Possis AngioJet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasound thrombolysis device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Platelet IIb/IIIa inhibitors
Number of subjects: 0
Study: 8882695

Group type: EXPERIMENTAL
Intervention: Hypotonic saline (7 patients)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Isotonic saline (5 patients)
Number of subjects: 12
Study: 2051379

Group type: EXPERIMENTAL
Intervention: Fixed partial dentures with periodontal therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (nonabutment) tooth
Number of subjects: 0
Study: 6842024

Group type: EXPERIMENTAL
Intervention: Tetracycline intravenously
Number of subjects: 12

Group type: COMPARATOR
Intervention: Procaine penicillin plus aluminum monostearate (PAM) intramuscularly
Number of subjects: 12
Study: 31004378

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice containing 520 mg nitrate
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice containing 520 mg nitrate and 6 g citrulline
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice containing 520 mg nitrate and 6 g arginine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 15
Study: 30086776

Group type: EXPERIMENTAL
Intervention: SGB with 6ml 1% lidocaine
Number of subjects: 38

Group type: COMPARATOR
Intervention: SGB with 6ml normal saline
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 38
Study: 26661464

Group type: EXPERIMENTAL
Intervention: ELF-MF exposure
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: RF-EMF exposure
Number of subjects: 50
Study: 24253314

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 1331

Group type: COMPARATOR
Intervention: Raloxifene
Number of subjects: 1331

Group type: EXPERIMENTAL
Intervention: Cognitive function (measured by 3MS score)
Number of subjects: 1331

Group type: EXPERIMENTAL
Intervention: Verbal memory
Number of subjects: 1331

Group type: EXPERIMENTAL
Intervention: Verbal fluency
Number of subjects: 1331
Study: 23155019

Group type: EXPERIMENTAL
Intervention: Liberal feeding (LIB)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Restricted feeding (R)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Inclusion of fiber (3% inulin or 3% cellulose)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Crude protein content (14.5% vs 17.4%)
Number of subjects: 360
Study: 19735336

Group type: EXPERIMENTAL
Intervention: Multimedia Learning Education Program (MLEP)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional Education Service Program (CESP)
Number of subjects: 54
Study: 17687129

Group type: EXPERIMENTAL
Intervention: Prophylaxis with recombinant factor VIII
Number of subjects: 65

Group type: COMPARATOR
Intervention: Enhanced episodic therapy
Number of subjects: 65
Study: 16192764

Group type: EXPERIMENTAL
Intervention: AQUAVAN Injection (AQ) at doses of 5, 10, 15, 20, 25, or 30 mg/kg
Number of subjects: 36

Group type: COMPARATOR
Intervention: PropofolD (lipid emulsion) at equipotent doses
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both AQ and PropofolD
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: AQ and PropofolGPI
Number of subjects: 36